Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cells|January 8, 2025
Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome ScreenSebastian Hoffmann, Benedict-Tilman Berger, Liane Rosalie Lucas, et al.
Molecular & Cellular Oncology|March 7, 2022
Resistance to kinase inhibition through shortened target engagementAziz M Rangwala, Benedict-Tilman Berger, Matthew B Robers, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Death by a Thousand Cuts â€" Combining Kinase Inhibitors for Selective Target Inhibition and Rational PolypharmacologyIan R Outhwaite, Sukrit Singh, Benedict-Tilman Berger, et al.
Elife|December 4, 2023
Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargetingIan R Outhwaite, Sukrit Singh, Benedict-Tilman Berger, et al.
Angewandte Chemie (International Ed. in English)|June 3, 2021
Controlling the Covalent Reactivity of a Kinase Inhibitor with LightMartin Reynders, Apirat Chaikuad, Benedict-Tilman Berger, et al.
STAR Protocols|September 27, 2021
Single tracer-based protocol for broad-spectrum kinase profiling in live cells with NanoBRETMatthew B Robers, Jennifer M Wilkinson, James D Vasta, et al.
European Journal of Medicinal Chemistry|February 26, 2021
Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine coreVáclav Němec, Lukáš Maier, Benedict-Tilman Berger, et al.
The Journal of Biological Chemistry|May 25, 2024
Splice variants of CK1α and CK1α-like: Comparative analysis of subcellular localization, kinase activity, and function in the Wnt signaling pathwayTomáš Gybeľ, Štěpán Čada, Darja Klementová, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Design and Synthesis of Pyrazole-Based Macrocyclic Kinase Inhibitors Targeting BMPR2Jennifer A Amrhein, Guiqun Wang, Benedict-Tilman Berger, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitorAndreas Krämer, Christian Georg Kurz, Benedict-Tilman Berger, et al.
Pageof 6